The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Nanodelivery of nucleic acids
Open accessAbstract
There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented opportunity to overcome these drawbacks; owing to their tunability with diverse physico-chemical properties, they can readily be functionalized with any type of biomolecules/moieties for selective targeting. Nucleic acid therapeutics such as antisense DNA, mRNA, small interfering RNA (siRNA) or microRNA (miRNA) have been widely explored to modulate DNA or RNA expression Strikingly, gene therapies combined with nanoscale delivery systems have broadened the therapeutic and biomedical applications of these molecules, such as bioanalysis, gene silencing, protein replacement and vaccines. Here, we overview how to design smart nucleic acid delivery methods, which provide functionality and efficacy in the layout of molecular diagnostics and therapeutic systems. It is crucial to outline some of the general design considerations of nucleic acid delivery nanoparticles, their extraordinary properties and the structure-function relationships of these nanomaterials with biological systems and diseased cells and tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Modulation of surface characteris tics may help to improve transduction and reduce the dose required, thereby reducing the risk of GTAU (Mendes et al., 2022; Carvalho et al., 2023).”
From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Mendes et al., 2022
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Research works printed but not linked: 1
- Malaviya, M. & Shiroya, M. Systemic gene delivery using lipid envelope systems and its potential in overcoming challenges. Int. J. Pharm. Drug Anal. 9, 46–55 (2021).
Cited by
Sorted by citations
Items 301–400 of 764
Ultra-Confined Controllable Cyclic Peptides as Supramolecularbiomaterials
Chorsi, M. T., Linthicum, W., Pozhidaeva, A., Mundrane, C., Mulligan, V. K., Chen, Y., Tavousi, P., Gorbatyuk, V., Vinogradova, O., Hoch, J. C., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2024.102247 · Cited by 11
Narum, S. M., Zhang, J., Vo, B., Mancuso, J. N., & Salaita, K. S. (2025) · ACS Nano · doi:10.1021/acsnano.5c00177 · Cited by 10
Extracellular vesicle-based targeted RNA therapies against cancer
Wang, Z., Xing, H., Huang, Y., & Lu, M. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100083 · Cited by 10
Ren, Z., Xu, L., Liu, J., Liu, K., Wei, D., Li, Q., Wei, W., Zhao, H., Lyu, Y., Liu, J., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c12434 · Cited by 10
Joshi, R., Sharma, S., Kapoor, D. U., Prajapati, B. G., Huanbutta, K., & Sriamornsak, P. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00774 · Cited by 10
Yang, B., Li, B., Zhu, Y., Zhao, M., Cheng, Y., Zhao, X., Teoh, D. E.-J., Wang, Y., Zhang, M., Tang, X., et al. (2026) · Nature Nanotechnology · doi:10.1038/s41565-025-02114-9 · Cited by 10
Machine learning-driven molecular engineering of nucleic acids
Shi, Q., Lv, H., Wang, F., Fan, C., & Li, M. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01091h · Cited by 10
Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy
Li, D., Li, J., Wang, S., Teng, W., & Wang, Q. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s383862 · Cited by 10
Li, X., Jin, D. S., Eadara, S., Caterina, M. J., & Meffert, M. K. (2023) · Neurobiology of Pain · doi:10.1016/j.ynpai.2023.100119 · Cited by 10
Nanotherapy to Reshape the Tumor Microenvironment: A New Strategy for Prostate Cancer Treatment
Deng, J., Yuan, S., Pan, W., Li, Q., & Chen, Z. (2024) · ACS Omega · doi:10.1021/acsomega.4c03055 · Cited by 10
Cunha, J., Ventura, F. V., Charrueau, C., & Ribeiro, A. J. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2405207 · Cited by 10
Yadav, K., Gnanakani, S. P. E., Sahu, K. K., Sucheta, Dubey, A., Minz, S., Raza, W., & Pradhan, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125049 · Cited by 10
Analysis of Nanomedicine Efficacy for Osteoarthritis
Wang, Y., Liu, L., Le, Z., & Tay, A. K. P. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200085 · Cited by 10
Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
Jin, S., & Sung, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147612 · Cited by 9
The Impact of Genetic Mutations on the Efficacy of Immunotherapies in Lung Cancer
Lui, K., Cheung, K., Ng, W. W. M., Wang, Y., Au, D. W. H., & Cho, W. C. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211954 · Cited by 9
Progress in skin gene therapy: From the inside and out
Osborn, M. J., Panda, S., Reineke, T. M., Tolar, J., & Nyström, A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.017 · Cited by 9
Song, Z., Wang, Q., Xiong, H., Xiao, J., Zhou, Z., Li, T., Sun, Q., Qiu, L., Tan, Y., Liu, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03404-z · Cited by 9
MicroRNA-Based Delivery Systems for Chronic Neuropathic Pain Treatment in Dorsal Root Ganglion
Jackson, S., Gigliobianco, M. R., Casadidio, C., Martino, P. D., & Censi, R. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070930 · Cited by 9
Anderluzzi, G., Mohamed, T., Moschetti, G., Favero, E. D., Rizzello, L., Magnaghi, V., Franzè, S., & Cilurzo, F. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s513568 · Cited by 9
Vertex Engineering of the Dodecaborate-Based Broadband Membrane Carriers
Wang, Y., Nelson, Y. A., Pomares, D. F. T., McCormick, C. M., Kerr, T. A., Gembický, M., & Spokoyny, A. M. (2025) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5c03660 · Cited by 9
Saidi, A. K. A. A., Al‐Shannaq, R., Ul‐Islam, M., Shehzad, A., Ahmad, M. W., Farid, M. M., Kamal, T., & Alshammari, F. H. (2025) · Materials Research Express · doi:10.1088/2053-1591/ae22c7 · Cited by 9
Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation
Wang, Y., Chen, C., Xiao, X. H., Kang, Y., He, J., Beloqui, A., & Xu, Y. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115741 · Cited by 9
The evolution of lipid nanoparticles: Paving the way for next-generation nucleic acid medicines
Lin, X., Xiang, H., Wu, J., Liao, R., Li, Y., Xu, B., Xu, Y., Shen, Y., Li, Q., & Tian, Y. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101121 · Cited by 7
Mesoporous Organosilica Nanoparticles with Tetrasulphide Bond to Enhance Plasmid DNA Delivery
Zhang, Y., Xian, H., Strounina, E. V., Gunther, K. S., Sweet, M. J., Chen, C., Yu, C., & Wang, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15031013 · Cited by 9
Chernonosova, V. S., Khlebnikova, M. I., Popova, V. K., Starostina, E. V., Владимировна, К. Е., Chelobanov, B. P., Kvon, R. I., Dmitrienko, E. V., & Laktionov, P. P. (2023) · Polymers · doi:10.3390/polym15153202 · Cited by 9
Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus
Chowdhury, N., & Kundu, A. K. (2023) · Diseases · doi:10.3390/diseases11040177 · Cited by 9
Sun, Y., Jiang, L., Zhang, Z., Xu, N., Jiang, Y., & Tan, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c14640 · Cited by 9
Hong, X., Chen, T., Liu, Y., Li, J., Huang, D., Ye, K., Liao, W., Wang, Y., Liu, M., & Luan, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102669 · Cited by 9
Targeting and engineering biomarkers for prostate cancer therapy
Senapati, D., Sahoo, S. K., Nayak, B. S., Senapati, S., Kundu, G. C., & Bhattamisra, S. K. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101359 · Cited by 9
Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Tamayo‐Trujillo, R., Guevara‐Ramírez, P., Paz‐Cruz, E., Cataña, M. A. C., & Zambrano, A. K. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1568828 · Cited by 9
Härk, H. H., Porosk, L., de Mello, L. R., Arukuusk, P., da Silva, E. R., & Kurrikoff, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030883 · Cited by 9
Lin, D., Piao, J., Wang, Y., Chen, Y., Shi, S., Cao, J., Shi, H., & Zhang, Q. (2024) · Composites Communications · doi:10.1016/j.coco.2024.101882 · Cited by 9
Engineering Asymmetric Nanoscale Vesicles for mRNA and Protein Delivery to Cells
Yang, C., Menge, J., Zhvania, N., Yu, M., Yang, H., Chen, D., Zheng, Z., Weitz, D. A., & Jahnke, K. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202505738 · Cited by 8
Jin, J., Liu, X., Zhu, G., Gao, X., Liu, X., Wang, Z., Xiao, B., Wang, P. G., & Zeng, C. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125843 · Cited by 8
Wei, X., Fan, G., Yang, S., Sun, X., & Cai, L. (2025) · Plant Biotechnology Journal · doi:10.1111/pbi.70189 · Cited by 8
Zheng, R., Prasad, A., Satyabola, D., Xu, Y., Roy, S., Yan, Y., Šulc, P., & Yan, H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c04918 · Cited by 8
Wang, R., Zhang, Y., Du, S., Li, Y., Ren, Y., & Lin, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s520329 · Cited by 8
Guiding design and performance of nonviral nucleic acid delivery vehicles via machine learning
Hutchinson, J. A., Panda, S., Rosales, P. D., Sowada, J. P., Willis, M. S., Leyden, M. C., Daoutidis, P., & Reineke, T. M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115739 · Cited by 8
Vasti, C., ́Alessandro, L. D., Bedoya, D. A., Valenti, L. E., & Giacomelli, C. E. (2025) · Hybrid Advances · doi:10.1016/j.hybadv.2025.100586 · Cited by 8
Biomarker-responsive nanomaterials for precision theranostics in inflammatory bowel disease
Li, Z., & Yang, Q. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217467 · Cited by 8
Volovăț, S. R., Augustin, I. G., Volovat, C. D., Ingrid, T. V., Ostafe, M. R., Panaite, D. I., Burlacu, A. I., & Volovăț, C. C. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010084 · Cited by 8
Biomaterial-assisted gene therapy for bone repair
Yang, L., Li, W., Yu, Y., Wang, H., & Wang, X. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102886 · Cited by 8
Silica nanoparticles as advanced platforms for nucleic acid delivery
Fanárraga, M. L., & García‐Hevia, L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102921 · Cited by 8
Unleashing the potential of mRNA : Overcoming delivery challenges with nanoparticles
Chen, Q., Huo, K.-G., Ji, S., Pang, S., Sun, T., Niu, Y., Jiang, Z., Zhang, P., Han, S., & Li, J. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10713 · Cited by 8
Tiberio, F., Salvati, M., Polito, L., Tisci, G., Vita, A., Parolini, O., Massimi, L., Pietro, L. D., Ceci, P., Tamburrini, G., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102427 · Cited by 8
Streamlining Bacterial Gene Regulation via Nucleic Acid Delivery with Gold Nanoclusters
Zhang, Q., Leng, X., Peng, L., Lin, H. Q., Xuan, G., Zhang, W., Mitomo, H., Ijiro, K., & Wang, G. (2025) · Small · doi:10.1002/smll.202411723 · Cited by 8
Uzma, & Xiong, H. (2025) · Talanta · doi:10.1016/j.talanta.2025.128029 · Cited by 8
Zheng, W., Zhang, Y., Gao, M. Y., & Qiu, M. (2023) · Chemical Communications · doi:10.1039/d3cc02624h · Cited by 8
Wei, K., He, M., Zhang, J., Zhao, C., Nie, C., Zhang, T., Liu, Y., Chen, T., Jiang, J., & Chu, X. (2023) · Angewandte Chemie · doi:10.1002/ange.202307025 · Cited by 8
Morales, L. C., Rajendran, A. P., Ansari, A. S., Remant, K. C., Nasrullah, M., Kiti, K., Yotsomnuk, P., Kulka, M., Sundaram, D. N. M., & Uludağ, H. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01077 · Cited by 8
Graphene Quantum Dots-Based Composites for Biomedical Applications
Alam, N., Ihsan, H., Khan, S. G., & Ullah, K. (2024) · Advances in chemical and materials engineering book series · doi:10.4018/979-8-3693-3268-9.ch004 · Cited by 8
Ju, J., Xu, D., Xu, L., Liu, J., Zeng, H., Zhao, B., Xiong, Y., Ma, Y., Ge, G., & Deng, H. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.113333 · Cited by 8
Setyawati, D. R., Azzahra, K., Mardliyati, E., Tarwadi, Yasinta, B., & Nurmeilis (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130705 · Cited by 8
Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development
Jia, Y., Zhou, Z., Jiramonai, L., Chen, J., Hua, Q., Zhu, M., Zhang, J., & Liang, X. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216718 · Cited by 7
Ihnatsyeu-Kachan, A., Saichuk, A., Sharko, O. L., Zhogla, V., Abashkin, V., Goff, W. L., Shmanai, V. V., Shcharbin, D., Guillas, I., & Kim, S. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108606 · Cited by 7
RNA‐Based Therapeutics: Cutting‐Edge Advances in Clinical Research
Ferreira, D., & Rodrigues, L. R. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500082 · Cited by 7
Beyond biologics: fungal polysaccharides as dual-function materials for nanomedicine
Wu, M., Zhang, W., Song, H., Hu, Y., & Li, W. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2540775 · Cited by 7
Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy
Kwak, S., Lee, H., Yu, D., Jeon, T., Kim, S. M., & Ryu, H. (2025) · Biosensors · doi:10.3390/bios15080504 · Cited by 7
Designing nucleic acid-based therapeutics for cancer treatment: Updates on the state of the art
Peng, B., Jayasinghe, M. K., Le, A. H., Tran, N. M., & Le, M. T. N. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.041 · Cited by 7
Deng, Y., Debbeler, J. P., Traeger, A., & Gaitzsch, J. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202500722 · Cited by 7
Liu, C. J. S., Wang, S.-B., Su, P.-Y., Hsieh, Y.-P., & Wang, H.-Y. A. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115851 · Cited by 7
Streiber, M., Schubert, U. S., & Traeger, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115023 · Cited by 7
Lin, X., Liu, J., Wu, G., Xiu, Y., Yan, W., Fan, N., & Li, H. (2024) · Cancer Nanotechnology · doi:10.1186/s12645-024-00287-x · Cited by 7
Roy, P., Kreofsky, N. W., & Reineke, T. M. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00925 · Cited by 7
Non-viral gene therapy for Leber’s congenital amaurosis: progress and possibilities
Abdulsalam, L., Mordecai, J., & Ahmad, I. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2443387 · Cited by 7
Fan, J., Xiao, Z., Dong, Y., Ye, F., Yan, Q., Zhang, C., Yin, X., Li, Y., & Wang, T. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402933 · Cited by 7
Zhou, H., Dai, J., Li, D., Wang, L., Ye, M., Hu, X., LoTurco, J. J., Hu, J., & Sun, W. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.006 · Cited by 7
Xu, O., Zhou, J., Xie, H., & Nie, W. (2025) · Small · doi:10.1002/smll.202503134 · Cited by 7
Rajesh, M. V., & Elumalai, K. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00376-4 · Cited by 7
Zhao, Z., Sun, F., Yu, H., Li, B., Wang, X., Sun, Y., & Yan, J. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114948 · Cited by 7
Glyco-nanomaterials as a therapeutic target in drug delivery and biomedicine: A review
Dessai, A. D., Nair, A., Selvasudha, N., Garg, S., & Nayak, U. Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147830 · Cited by 7
Wang, T., Li, Q., Xu, R., Zhao, Z., Sun, Q., Xu, X., & Li, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1437071 · Cited by 7
Hypoxia-driven ncRNAs in breast cancer
Al-Zuaini, H. H., Zahid, K. R., Xiao, X., Raza, U., Huang, Q., & Zeng, T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1207253 · Cited by 7
Role of Surface Coatings in Preventing Nanoparticle Aggregation Induced by Freeze-Drying
Albuquerque, L. J. C., Carvalho, J. T. T., Fidelis, C. L., Stefanello, T. F., Ceolín, M. R., Cardoso, M. B., & Picco, A. S. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c02655 · Cited by 6
Park, S. J., Lee, D. H., Yoon, K. B., Kim, A. Y., Jung, C.-Y., Kim, S. T., Brito, S., & Bin, B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091136 · Cited by 6
Xu, Z., Cheng, X., Guo, X., Li, P., Li, J., Zhao, J., & Wang, Z. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202516456 · Cited by 6
Darji, S., Qu, F., Henager, M. E., Prasad, A., Elzey, B. D., Ferreira, C. G., & Thompson, D. H. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502486122 · Cited by 6
Zwitterionic Polybetaines: A versatile platform for stealth and functional drug delivery
Dou, S., Li, H., Chen, M., Li, W., Ying, B., Ma, Y., Zhang, R., Li, S., Zhang, H., Sun, Y., et al. (2026) · European Polymer Journal · doi:10.1016/j.eurpolymj.2026.114562 · Cited by 6
Peptide dendrimers transfecting CRISPR/Cas9 plasmid DNA: optimization and mechanism
Zamolo, S., Zakharova, E., Boursinhac, L., Hollfelder, F., Darbre, T., & Reymond, J. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00116h · Cited by 6
Saba, I., Batoo, K. M., Wani, K., Verma, R., & Hameed, S. (2024) · Cureus · doi:10.7759/cureus.69556 · Cited by 6
Unlocking the Molecular Targets in Non-Small-Cell Lung Cancer and a Nanomedicine-Based Remedy
Sarma, K., Akhter, M. H., Alalmaie, A., Ahmad, I., Ansari, M. N., Khalilullah, H., Farhana, S. A., Hussain, S. M., & Aljadaan, A. M. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2024053289 · Cited by 6
Ukwubile, C. A., Yesufu, H. B., Okoro, R. N., Ahuchaogu, A. A., Umeokoli, B. O., Agu, M. O., Menkiti, N. D., & Ida, P. A. (2025) · Next Nanotechnology · doi:10.1016/j.nxnano.2025.100191 · Cited by 6
DNA nanotherapeutics facilitate efficient gynecological cancers treatment
Zheng, X., Zhuang, J., Peng, X., Zhang, Y., Chen, D. F., & Chen, B. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114336 · Cited by 6
Progress on RNA-based therapeutics for genetic diseases
Ting, L. U. O., Huo, C., Zhou, T., & Xie, S. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0190 · Cited by 6
Korzun, T., Moses, A. S., Diba, P., Sattler, A. L., Olson, B. G., Taratula, O. R., Pejovic, T. B., Marks, D. L., & Taratula, O. (2023) · Small · doi:10.1002/smll.202301776 · Cited by 6
CRISPR Cas-9 for treatment and control of Avian viral diseases: challenges and opportunities
Ullah, A., Khan, M., Akram, M., Abdullah, M., Sayka, S., Iqbal, I., Siddique, F., Arain, M. A., Hassan, F., & Shafi, M. (2024) · World s Poultry Science Journal · doi:10.1080/00439339.2024.2344124 · Cited by 6
Nano-delivery platforms for bacterial gene transformation: suitability and challenges
Kaur, H., Kalia, A., Manchanda, P., & Singh, A. (2024) · International Microbiology · doi:10.1007/s10123-024-00543-5 · Cited by 6
Nanoparticles for Cancer Gene Therapy and Imaging
Fernandes, D. A. (2024) · Biomedical Materials & Devices · doi:10.1007/s44174-024-00235-8 · Cited by 6
Geometrically constrained cytoskeletal reorganisation modulates DNA nanostructures uptake
Elblová, P., Andělová, H., Lunová, M., Anthi, J., Henry, S. J. W., Tu, X., Dejneka, A., Jirsa, M., Stephanopoulos, N., & Lunov, O. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00074b · Cited by 6
Stimuli-Responsive Non-viral Nanoparticles for Gene Delivery
Reichel, L. S., & Traeger, A. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_694 · Cited by 6
Development of nano-immunotherapy for cancer treatment: achievements and scopes
Raj, A., Babu, A., Kothandan, V. K., Park, I., & Hwang, S. R. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00644-9 · Cited by 6
Laturski, A. E., Dulay, M. T., Perry, J. L., & DeSimone, J. M. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00028 · Cited by 6
Physical principles at bio-nano interfaces with active matter
Jin, X., Wan, H., Jiao, Z., Li, J., & Yan, L. (2024) · National Science Open · doi:10.1360/nso/20230079 · Cited by 5
Mmbando, G. S. (2024) · Journal of Crop Improvement · doi:10.1080/15427528.2024.2385818 · Cited by 5
Nanomedicine for ovarian cancer: Enhancing pharmacokinetics and biodistribution
Saddick, S. (2024) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2024.103584 · Cited by 5
Light-controlled assembly and disassembly of cyclodextrin-bisazobenzene supramolecular complexes
Fernández-Clavero, C., Rivero-Barbarroja, G., Carmona, T., García‐Iriepa, C., Marcelo, G., de Ilarduya, C. T., Mellet, C. O., Fernández, J. M. G., Benito, J. M., & Mendicuti, F. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.113849 · Cited by 5
Li, X., Li, Y., Zhu, J., Yang, Y., & Yang, S. (2025) · Discover Nano · doi:10.1186/s11671-025-04226-6 · Cited by 5
Immune Modulation with Oral DNA/RNA Nanoparticles
Kart, U., Raimbekova, A., Yegorov, S., & Hortelano, G. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050609 · Cited by 5
A multistage microRNA nanotherapeutic to address fibrosis of bacterial keratitis
Zhao, R., Zheng, Y., Xu, K., Huang, L., Ding, J., Shang, X., Tao, X., Xin, S., Zheng, Q., Qian, Y., et al. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102800 · Cited by 5
Alissa, M., Alghamdi, A. A., Alghamdi, S. A., Alshehri, M. A., Aloraini, G. S., Albelasi, A., & Alshammari, M. S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144881 · Cited by 5
Metadata
- Authors
- Mendes, B. B., Conniot, J., Avital, A., Yao, D., Jiang, X., Zhou, X., Sharf-Pauker, N., Xiao, Y., Adir, O., Liang, H., Shi, J., Schroeder, A., & Conde, J.
- Affiliations
- Ningbo University (CN)
- University of Science and Technology of China (CN)
- Brigham and Women's Hospital (US)
- Technion – Israel Institute of Technology (IL)
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Liang, Haojun
- Shi, Jinjun
- Schroeder, Avi
- Conde, João
- ORCID
- Venue
- Nature Reviews Methods Primers
- Published
- 2022-04-14
- Volume
- 2
- Issue
- 1
- ISSN
- 2662-8449 (ISSN-L)
- PMC
- PMC9038125
- OpenAlex
- W4223968391
- Cited by
- 719
- References
- 228
- Citations by year
- 2026: 166 · 2025: 233 · 2024: 196 · 2023: 103 · 2022: 21
- FWCI
- 14.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature Reviews Methods Primers (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- U.S. Department of Veterans Affairs (I01 BX004426)
- American Lung Association
- Massachusetts General Hospital
- National Natural Science Foundation of China (52003264, 21991132, 52033010, 2020YFA0710700, 52021002)
- National Institutes of Health
- Fundação para a Ciência e a Tecnologia (PTDC/BTM-MAT/4738/2020)
- Fundamental Research Funds for the Central Universities
- National Heart, Lung, and Blood Institute (R01HL159012, R01HL156362, R01HL137229, R01HL158097, R01HL162367)
- National Cancer Institute (R01CA200900)
- H2020 European Research Council (848325)
- DOD Peer Reviewed Cancer Research Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- nucleic acid delivery, nanodelivery, gene therapy, nanoparticles, siRNA, microRNA, antisense DNA, mRNA therapeutics, targeted delivery, structure-function relationship, molecular diagnosis, gene silencing, vaccines, protein replacement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review